Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting an interface or release version change rather than any new study details.SummaryDifference0.0%

- Check27 days agoChange DetectedAddition: Revision: v3.5.2; Deletion: Revision: v3.5.0. The page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.5.0 was applied, updating from v3.4.3.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check92 days agoChange DetectedStudy Documents now lists Revision 3.4.2 for the protocol and related documents, replacing Revision 3.4.1.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.